T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Workday
WDAY
$44.6B
| $4.58B | 0.64% |
22,291,955
-393,174
| -2% | -$79.4M |
|
27
Vertex Pharmaceuticals
VRTX
$135B
| $4.56B | 0.64% |
24,885,881
-1,260,763
| -5% | -$220M |
|
28
Cigna
CI
$72B
| $4.4B | 0.62% |
27,938,708
-2,417,017
| -8% | -$379M |
|
29
JPMorgan Chase
JPM
$964B
| $4.2B | 0.59% |
37,531,148
-499,578
| -1% | -$55.1M |
|
30
Pfizer
PFE
$151B
| $4.05B | 0.57% |
98,429,744
-14,433,533
| -13% | -$573M |
|
31
Fortive
FTV
$18.7B
| $3.95B | 0.55% |
76,800,364
+2,186,429
| +3% | +$114M |
|
32
GE Aerospace
GE
$382B
| $3.84B | 0.54% |
73,345,894
+15,287,113
| +26% | +$753M |
|
|
33
American International
AIG
$40.6B
| $3.71B | 0.52% |
69,649,901
+26,800,863
| +63% | +$1.34B |
|
34
Wells Fargo
WFC
$265B
| $3.71B | 0.52% |
78,392,868
+3,995,403
| +5% | +$187M |
|
35
NextEra Energy
NEE
$178B
| $3.71B | 0.52% |
72,394,332
+10,143,984
| +16% | +$499M |
|
36
Aptiv
APTV
$10.3B
| $3.66B | 0.51% |
45,290,324
+2,805,856
| +7% | +$222M |
|
37
ServiceNow
NOW
$131B
| $3.55B | 0.5% |
64,718,815
-359,495
| -0.6% | -$18.9M |
|
38
Dollar General
DG
$26.5B
| $3.47B | 0.49% |
25,655,326
+957,133
| +4% | +$121M |
|
39
Northrop Grumman
NOC
$81.8B
| $3.47B | 0.49% |
10,725,371
-93,184
| -0.9% | -$27.8M |
|
|
AMTD
40
DELISTED
TD Ameritrade Holding Corp
AMTD
| $3.46B | 0.49% |
69,215,623
-5,081,302
| -7% | -$263M |
|
41
McDonald's
MCD
$193B
| $3.44B | 0.48% |
16,562,216
+1,640,747
| +11% | +$325M |
|
42
Intercontinental Exchange
ICE
$84.6B
| $3.4B | 0.48% |
39,511,852
+1,501,237
| +4% | +$123M |
|
43
Global Payments
GPN
$22.8B
| $3.31B | 0.47% |
20,699,119
+1,392,325
| +7% | +$207M |
|
|
WP
44
DELISTED
Worldpay, Inc.
WP
| $3.23B | 0.45% |
26,367,683
-1,750,948
| -6% | -$208M |
|
|
MRSH
45
Marsh
MRSH
$91.7B
| $3.22B | 0.45% |
32,309,284
-1,930,085
| -6% | -$185M |
|
46
Cisco
CSCO
$474B
| $3.15B | 0.44% |
57,598,589
-6,480,834
| -10% | -$358M |
|
47
Willis Towers Watson
WTW
$32B
| $3.1B | 0.44% |
16,189,692
+556,935
| +4% | +$101M |
|
48
Walt Disney
DIS
$178B
| $3.07B | 0.43% |
22,012,053
+2,939,011
| +15% | +$390M |
|
|
SPLK
49
DELISTED
Splunk Inc
SPLK
| $3.05B | 0.43% |
24,287,809
+1,942,047
| +9% | +$247M |
|
50
Tyson Foods
TSN
$20B
| $3B | 0.42% |
37,150,401
-503,897
| -1% | -$38.8M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.